YAN Mingxi, ZHU Min, QUAN Fei, et al. Acupoint thread-embedding at fat layer for abdominal obesity: a randomized controlled trial[J]. Chinese Acupuncture & Moxibustion, 2024, 44(12): 1370-1376.
DOI:
YAN Mingxi, ZHU Min, QUAN Fei, et al. Acupoint thread-embedding at fat layer for abdominal obesity: a randomized controlled trial[J]. Chinese Acupuncture & Moxibustion, 2024, 44(12): 1370-1376.DOI: 10.13703/j.0255-2930.20240517-k0005.
Acupoint thread-embedding at fat layer for abdominal obesity: a randomized controlled trial
To observe the clinical efficacy of acupoint thread-embedding at fat layer for abdominal obesity and its effects on glucose and lipid metabolism.
Methods
2
Ninety-six patients with abdominal obesity were randomly divided into an acupoint embedding group (48 cases
3 cases dropped out) and a sham embedding group (48 cases
3 cases dropped out). Both groups received lifestyle interventions as basic treatment. The acupoint embedding group underwent thread-embedding at Zhongwan (CV 12)
Qihai (CV 6)
Guanyuan (CV 4)
and bilateral Liangmen (ST 21)
Fenglong (ST 40)
and Pishu (BL 20)
with the thread implanted in the fat layer. The sham embedding group followed the same acupoint selection and procedure but without catgut implantation. Both groups were treated once every two weeks for 12 weeks
for a total of six treatments. Waist circumference
body weight
body mass index (BMI)
waist-to-hip ratio (WHR)
and waist-to-height ratio (WHtR) were measured
and appetite was assessed using the visual analogue scale (VAS) before and after treatment and at 12 weeks after treatment completion (follow-up) in the two groups. Visceral fat area (VFA) and subcutaneous fat area (SFA) at abdomen were measured
and blood glucose and lipid metabolism markers
including fasting blood glucose (FBG)
fasting insulin (FINS)
homeostasis model assessment of insulin resistance (HOMA-IR) index
total cholesterol (TC)
triglycerides (TG)
high-density lipoprotein cholesterol (HDL-C)
low-density lipoprotein cholesterol (LDL-C)
leptin
tumor necrosis factor-α(TNF-α)
and interleukin-6 (IL-6)
were also tested before and after treatment in the two groups. Clinical efficacy was evaluated two weeks after treatment completion.
Results
2
After treatment and at follow-up
the waist circumference
body weight
BMI
WHR
WHtR
and appetite VAS scores in the acupoint embedding group were decreased compared to those before treatment (
P
<
0.01). In the sham embedding group
waist circumference
body weight
BMI
WHtR
and appetite VAS score were also reduced after treatment compared to those before treatment (
P
<
0.01). Except for body weight after treatment
the acupoint embedding group showed lower waist circumference
body weight
BMI
WHR
and WHtR values after treatment and at follow-up compared to the sham embedding group (
P
<
0.01
P
<
0.05). Additionally
the appetite VAS score in the acupoint embedding group was lower than that in the sham embedding group after treatment (
P
<
0.01). Both groups showed a reduction in abdominal VFA and SFA after treatment compared to those before treatment (
P
<
0.01
P
<
0.05). In the acupoint embedding group
serum FBG
FINS
HOMA-IR index
TC
TG
LDL-C
leptin
TNF-α
and IL-6 levels were decreased compared to those before treatment (
P
<
0.01)
while HDL-C level was increased (
P
<
0.01). In the sham embedding group
serum FBG and HOMA-IR index were decreased compared to those before treatment (
P
<
0.01
P
<
0.05). After treatment
the abdominal SFA in the acupoint embedding group was lower than that in the sham embedding group (
P
<
0.01). Additionally
the acupoint embedding group had lower levels of serum FINS
HOMA-IR index
TC
LDL-C
leptin
TNF-α
and IL-6 compared to the sham embedding group (
P
<
0.05
P
<
0.01). The total effective rate in the acupoint embedding group was 82.2% (37/45)
which was significantly higher than 15.6% (7/45) in the sham embedding group (
P
<
0.01).
Conclusion
2
The acupoint catgut embedding at fat layer could effectively reduce the obesity severity in patients with abdominal obesity